VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ESNT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ESNTEssent Group Ltd.
$64.83$6.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksESNTQuarterly Financials

Essent Group Ltd. (ESNT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Essent Group Ltd. (ESNT) quarterly income statement — complete revenue, gross profit & net income history

ESNT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue329.63M312.4M318.73M326.05M324.07M339.27M316.58M318.66M303.91M297.28M296.11M260.13M256.25M230.04M261.77M244.41M264.61M256.92M283.54M243.26M
Revenue Growth %1.72%-7.92%0.68%2.32%6.63%14.13%6.91%22.5%18.6%29.23%13.12%6.43%-3.16%-10.46%-7.68%0.47%8.09%3.93%16.66%3.04%
Medical Costs & Claims48.22M56.07M44.92M17.05M31.29M40.98M30.67M-334K9.91M19.64M10.82M1.26M-180K4.1M4.25M-76.2M-106.86M-3.43M-7.48M9.65M
Medical Cost Ratio %14.63%17.95%14.09%5.23%9.65%12.08%9.69%-0.1%3.26%6.61%3.65%0.48%-0.07%1.78%1.62%-31.18%-40.38%-1.34%-2.64%3.97%
Gross Profit281.41M256.33M273.8M309M292.78M298.3M285.91M318.99M294M277.64M285.29M258.87M256.43M225.94M257.51M320.61M371.47M260.35M291.02M233.61M
Gross Margin %85.37%82.05%85.91%94.77%90.35%87.92%90.31%100.1%96.74%93.39%96.35%99.52%100.07%98.22%98.38%131.18%140.38%101.34%102.64%96.03%
Gross Profit Growth %-3.88%-14.07%-4.24%-3.13%-0.41%7.44%0.22%23.23%14.65%22.88%10.78%-19.26%-30.97%-13.22%-11.51%37.24%74.83%40.63%55%288.06%
Operating Expenses74.69M71.8M74.64M77.82M85.78M103.35M78.34M79.77M80.25M74.68M75.84M49.57M55.13M52.94M46.59M44.78M43.02M43.33M44.34M43.19M
OpEx / Revenue %22.66%22.98%23.42%23.87%26.47%30.46%24.75%25.03%26.41%25.12%25.61%19.06%21.51%23.02%17.8%18.32%16.26%16.86%15.64%17.75%
Depreciation & Amortization1.23M1.25M1.26M1.34M1.37M1.43M1.49M1.47M1.39M1.34M1.74M741K698K794K740K735K755K801K855K860K
Combined Ratio %37.28%40.93%37.51%29.1%36.12%42.54%34.43%24.93%29.67%31.73%29.27%19.54%21.44%24.8%19.42%-12.85%-24.12%15.53%13%21.72%
Operating Income206.72M184.53M199.16M231.18M207M194.95M207.57M239.22M213.74M202.96M209.44M209.3M201.29M172.99M210.92M275.82M328.45M217.02M246.68M190.42M
Operating Margin %62.72%59.07%62.49%70.9%63.88%57.46%65.57%75.07%70.33%68.27%70.73%80.46%78.56%75.2%80.58%112.85%124.12%84.47%87%78.28%
Operating Income Growth %-0.13%-5.35%-4.05%-3.36%-3.15%-3.95%-0.89%14.3%6.18%17.32%-0.7%-24.12%-38.71%-20.29%-14.5%44.85%95.29%48.49%66.19%912.08%
EBITDA207.96M185.78M200.42M232.52M208.37M196.38M209.07M240.69M215.13M204.3M211.19M210.04M201.99M173.79M211.66M276.56M329.2M217.82M247.54M191.28M
EBITDA Margin %63.09%59.47%62.88%71.31%64.3%57.88%66.04%75.53%70.79%68.72%71.32%80.75%78.83%75.55%80.86%113.15%124.41%84.78%87.3%78.63%
Interest Expense8.15M8.15M8.25M8.15M8.15M8.15M11.46M7.85M7.86M7.95M7.85M7.39M6.94M6.04M4.45M2.89M2.23M2.1M2.06M2.07M
Non-Operating Income-8.15M-8.15M-8.25M-8.15M-8.15M-8.15M-11.46M-7.85M-7.86M-7.95M-7.85M-7.39M-6.94M-6.05M-4.45M-2.89M-2.23M-2.1M-2.06M-2.07M
Pretax Income206.72M184.53M199.16M231.18M207M194.95M207.57M239.22M213.74M202.96M209.44M209.3M201.29M173M210.92M275.82M328.45M217.02M246.68M190.42M
Pretax Margin %62.72%59.07%62.49%70.9%63.88%57.46%65.57%75.07%70.33%68.27%70.73%80.46%78.56%75.2%80.58%112.85%124.12%84.47%87%78.28%
Income Tax34.93M29.55M34.94M35.84M31.57M27.05M31.4M35.62M32.02M27.59M31.48M37.07M30.47M25.63M32.87M44.05M54.28M36.03M41.33M30.63M
Effective Tax Rate %16.89%16.01%17.55%15.5%15.25%13.88%15.13%14.89%14.98%13.6%15.03%17.71%15.14%14.82%15.58%15.97%16.53%16.6%16.75%16.08%
Net Income171.8M154.98M164.22M195.34M175.43M167.9M176.18M203.61M181.72M175.37M177.96M172.23M170.83M147.37M178.05M231.77M274.17M180.99M205.35M159.79M
Net Margin %52.12%49.61%51.52%59.91%54.13%49.49%55.65%63.9%59.79%58.99%60.1%66.21%66.67%64.06%68.02%94.83%103.61%70.45%72.43%65.69%
Net Income Growth %-2.07%-7.69%-6.79%-4.06%-3.46%-4.26%-1%18.22%6.38%19%-0.05%-25.69%-37.69%-18.58%-13.3%45.04%102.12%46.43%64.89%938.98%
EPS (Diluted)1.821.601.671.931.691.581.651.911.701.641.661.611.591.371.662.162.521.641.841.42
EPS Growth %7.69%1.27%1.21%1.05%-0.59%-3.66%-0.6%18.63%6.92%19.71%0%-25.46%-36.9%-16.46%-9.78%52.11%108.26%49.09%65.77%846.67%
EPS (Basic)1.831.621.691.951.711.601.671.931.721.661.681.621.601.381.672.172.531.651.851.43
Diluted Shares Outstanding94.57M96.66M101.16M101.06M103.95M106.1M106.55M106.78M106.77M106.82M107.03M107.09M107.58M107.42M107.34M107.28M108.59M110.03M111.39M112.45M